DR. HAFEEZ T CHATOOR M.D. NPI 1174533194

NPI Information

  • NPI: 1174533194
  • Provider Name: DR. HAFEEZ T CHATOOR, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3402 W DR MARTIN LUTHER KING JR BLVD
    TAMPA, FL
    ZIP 33607
  • Phone: (813) 875-3950

Map and Directions

Get Directions

NPI Details

DR. Hafeez T Chatoor, M.D. is a medical oncology internal medicine in Tampa, FL with 41 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Hafeez T Chatoor, M.D. NPI is 1174533194. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Graduation Year:1985

The provider's business location address is:

3402 W DR MARTIN LUTHER KING JR BLVD
TAMPA, FL
ZIP 33607-214
Phone: (813) 875-3950
Fax: (813) 872-2741

The NPI 1174533194 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Protein measurement, serum (HCPCS:84165)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Blood test, clotting time (HCPCS:85610)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Uric acid level, blood (HCPCS:84550)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Folic acid level, serum (HCPCS:82746)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Red blood count, automated test (HCPCS:85045)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Red blood count, manual test (HCPCS:85044)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Erythropoietin (protein) level (HCPCS:82668)

The enumeration date for this NPI number is 8/9/2006 and was last updated on 7/9/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME60783FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME60783FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1251273400MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.